Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon‐like peptide‐1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD ‐4 substudy
Year: 2016
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12705
Institutions: Örebro University, Harvard University, Eli Lilly (United States)
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W2409477315
